<DOC>
	<DOC>NCT02215889</DOC>
	<brief_summary>The patients will receive hepatectomy as a 2 stage procedure. In the first surgical procedure liver segments 2-3 are removed and liver donor segments 2-3 inserted. After growth of donor segments 2-3, the remaining liver segments of the recipient are removed. The patient will at this time have only donor liver tissue in place.</brief_summary>
	<brief_title>Partial Liver Segment 2/3 Transplantation Study</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>Histologically verified adenocarcinoma in colon/rectum. Liver metastases, not amenable to liver resection No signs of extra hepatic metastatic disease or local recurrence according to PET/CT scan within 4 weeks prior to the faculty meeting at the transplant unit, except patients may have 13 resectable lung lesions all&lt;15mm. No signs of extra hepatic metastatic disease on CT thorax/abdomen/pelvis within 4 weeks prior to the faculty meeting at the transplant unit, except patients may have 13 resectable lung lesions all&lt;15mm. No local recurrence according to MRpelvis scan in patients with rectal cancer within 4 weeks prior to the faculty meeting at the transplant unit No signs of local recurrence judged by colonoscopy / CT colography within 12 months prior to the faculty meeting at the transplant unit Good performance status, ECOG 0 or 1. Satisfactory blood tests: Hb &gt;10g/dl, neutrophiles &gt;1.0 (after any GCSF), TRC &gt;75, Bilirubin&lt;2 x upper normal level, ASAT,ALAT&lt;5 x upper normal level, Creatinine &lt;1.25 x upper normal level. Albumin above lower normal level. Signed informed consent and expected cooperation of the patients for the treatment and follow up must be obtained and documented according to GCP, and national/local regulations. All patients should have received at least 8 weeks of chemotherapy. Weight loss &gt;10% the last 6 months Patient BMI &gt; 30 Previous diagnosed bone or CNS metastatic disease. Previous diagnosed cancer mammae or malignant melanoma. Palliative resection of primary CRC tumor.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Liver metastases</keyword>
	<keyword>Transplantation</keyword>
</DOC>